Cytek Biosciences Debuts Optimized Immunoprofiling Kit
December 15, 2020 10:00 ET | Cytek Biosciences
FREMONT, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- It just became easier, faster and more efficient to profile the human immune system. Cytek Biosciences Inc., a leading provider of cell analysis...
LogoPressRelease.jpg
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 20, 2020 21:54 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Completes Acquisition of InstruNor AS
February 26, 2020 08:30 ET | Fluidigm Corporation
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. ...
LogoPressRelease.jpg
Fluidigm Receives Life Science Industry Award for the Maxpar Direct Immune Profiling System
December 09, 2019 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm serving the life science tools market, recognized Fluidigm...
LogoPressRelease.jpg
Fluidigm Drives a New Standard in Human Immune Profiling
November 05, 2019 16:02 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it has exceeded $1 million in revenue from its industry-leading Maxpar® Direct™...
LogoPressRelease.jpg
Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels
September 24, 2019 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces 8th Annual Mass Cytometry Summit
April 30, 2019 09:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
cofactor_logo.jpg
Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
October 30, 2018 08:00 ET | Cofactor Genomics
--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions-- SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cofactor...
cofactor_logo.jpg
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
October 02, 2018 08:00 ET | Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
cofactor_logo.jpg
Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay
March 20, 2018 08:30 ET | Cofactor Genomics
SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...